Дмитренко, І. В. “Prognostic Value of Early Reduction of BCR/ABL1 Gene Expression in Criteria of Deep Molecular Response on Imatynib Therapy in Patients With Chronic Myeloid Leukemia”. Problems of Environmental Biotechnology, no. 1, June 2018, doi:10.18372/2306-6407.1.12851.